Cargando…
Major Histocompatibility Complex Class I–restricted Cross-presentation Is Biased towards High Dose Antigens and Those Released during Cellular Destruction
Naive T cells recirculate mainly within the secondary lymphoid compartment, but once activated they can enter peripheral tissues and perform effector functions. To activate naive T cells, foreign antigens must traffic from the site of infection to the draining lymph nodes, where they can be presente...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212442/ https://www.ncbi.nlm.nih.gov/pubmed/9670054 |
_version_ | 1782148695342448640 |
---|---|
author | Kurts, Christian Miller, Jacques F.A.P. Subramaniam, Rathan M. Carbone, Francis R. Heath, William R. |
author_facet | Kurts, Christian Miller, Jacques F.A.P. Subramaniam, Rathan M. Carbone, Francis R. Heath, William R. |
author_sort | Kurts, Christian |
collection | PubMed |
description | Naive T cells recirculate mainly within the secondary lymphoid compartment, but once activated they can enter peripheral tissues and perform effector functions. To activate naive T cells, foreign antigens must traffic from the site of infection to the draining lymph nodes, where they can be presented by professional antigen presenting cells. For major histocompatibility complex class I–restricted presentation to CD8(+) T cells, this can occur via the cross-presentation pathway. Here, we investigated the conditions allowing antigen access to this pathway. We show that the level of antigen expressed by peripheral tissues must be relatively high to facilitate cross-presentation to naive CD8(+) T cells. Below this level, peripheral antigens did not stimulate by cross-presentation and were ignored by naive CD8(+) T cells, although they could sensitize tissue cells for destruction by activated cytotoxic T lymphocytes (CTLs). Interestingly, CTL-mediated tissue destruction facilitated cross-presentation of low dose antigens for activation of naive CD8(+) T cells. This represents the first in vivo evidence that cellular destruction can enhance access of exogenous antigens to the cross-presentation pathway. These data indicate that the cross-presentation pathway focuses on high dose antigens and those released during tissue destruction. |
format | Text |
id | pubmed-2212442 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1998 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-22124422008-04-16 Major Histocompatibility Complex Class I–restricted Cross-presentation Is Biased towards High Dose Antigens and Those Released during Cellular Destruction Kurts, Christian Miller, Jacques F.A.P. Subramaniam, Rathan M. Carbone, Francis R. Heath, William R. J Exp Med Brief Definitive Reports Naive T cells recirculate mainly within the secondary lymphoid compartment, but once activated they can enter peripheral tissues and perform effector functions. To activate naive T cells, foreign antigens must traffic from the site of infection to the draining lymph nodes, where they can be presented by professional antigen presenting cells. For major histocompatibility complex class I–restricted presentation to CD8(+) T cells, this can occur via the cross-presentation pathway. Here, we investigated the conditions allowing antigen access to this pathway. We show that the level of antigen expressed by peripheral tissues must be relatively high to facilitate cross-presentation to naive CD8(+) T cells. Below this level, peripheral antigens did not stimulate by cross-presentation and were ignored by naive CD8(+) T cells, although they could sensitize tissue cells for destruction by activated cytotoxic T lymphocytes (CTLs). Interestingly, CTL-mediated tissue destruction facilitated cross-presentation of low dose antigens for activation of naive CD8(+) T cells. This represents the first in vivo evidence that cellular destruction can enhance access of exogenous antigens to the cross-presentation pathway. These data indicate that the cross-presentation pathway focuses on high dose antigens and those released during tissue destruction. The Rockefeller University Press 1998-07-20 /pmc/articles/PMC2212442/ /pubmed/9670054 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Brief Definitive Reports Kurts, Christian Miller, Jacques F.A.P. Subramaniam, Rathan M. Carbone, Francis R. Heath, William R. Major Histocompatibility Complex Class I–restricted Cross-presentation Is Biased towards High Dose Antigens and Those Released during Cellular Destruction |
title | Major Histocompatibility Complex Class I–restricted Cross-presentation Is Biased towards High Dose Antigens and Those Released during Cellular Destruction |
title_full | Major Histocompatibility Complex Class I–restricted Cross-presentation Is Biased towards High Dose Antigens and Those Released during Cellular Destruction |
title_fullStr | Major Histocompatibility Complex Class I–restricted Cross-presentation Is Biased towards High Dose Antigens and Those Released during Cellular Destruction |
title_full_unstemmed | Major Histocompatibility Complex Class I–restricted Cross-presentation Is Biased towards High Dose Antigens and Those Released during Cellular Destruction |
title_short | Major Histocompatibility Complex Class I–restricted Cross-presentation Is Biased towards High Dose Antigens and Those Released during Cellular Destruction |
title_sort | major histocompatibility complex class i–restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction |
topic | Brief Definitive Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212442/ https://www.ncbi.nlm.nih.gov/pubmed/9670054 |
work_keys_str_mv | AT kurtschristian majorhistocompatibilitycomplexclassirestrictedcrosspresentationisbiasedtowardshighdoseantigensandthosereleasedduringcellulardestruction AT millerjacquesfap majorhistocompatibilitycomplexclassirestrictedcrosspresentationisbiasedtowardshighdoseantigensandthosereleasedduringcellulardestruction AT subramaniamrathanm majorhistocompatibilitycomplexclassirestrictedcrosspresentationisbiasedtowardshighdoseantigensandthosereleasedduringcellulardestruction AT carbonefrancisr majorhistocompatibilitycomplexclassirestrictedcrosspresentationisbiasedtowardshighdoseantigensandthosereleasedduringcellulardestruction AT heathwilliamr majorhistocompatibilitycomplexclassirestrictedcrosspresentationisbiasedtowardshighdoseantigensandthosereleasedduringcellulardestruction |